Ativan (lorazepam) treats catatonia by boosting the brain’s primary calming chemical, GABA, which reduces the abnormal neural overactivity behind catatonic symptoms. It works remarkably fast. Patients who are completely mute or frozen can begin speaking and moving again within 10 minutes to 2 hours of receiving a dose. This rapid, dramatic response is one of the reasons lorazepam is the standard first-line treatment for catatonia, with reported response rates ranging from 66% to 100% depending on the study.
What Happens in the Brain During Catatonia
Catatonia involves excessive activation in motor planning areas of the brain, particularly a region called the supplementary motor area. Think of it as the brain’s movement-initiation system getting stuck in overdrive, which paradoxically can lock a person into immobility, mutism, or repetitive postures. The neurotransmitter GABA, which normally dials down neural activity, appears to be functioning insufficiently in these circuits.
Lorazepam is what pharmacologists call an allosteric modulator of the GABA-A receptor. In practical terms, it doesn’t activate the receptor directly. Instead, it makes the receptor more responsive to the GABA already present in the brain, increasing the frequency with which the receptor’s chloride channel opens. When chloride flows into neurons, those neurons become less excitable. The net effect is a widespread calming of overactive brain circuits, which is why catatonic symptoms can resolve so quickly once the drug takes effect.
How Quickly Symptoms Improve
The speed of response is one of the most striking things about lorazepam in catatonia. In a prospective trial, patients who received 2 mg intravenously showed significant drops in catatonia severity scores within five minutes. Clinicians who treat catatonia regularly describe watching patients go from completely mute and motionless to speaking and eating within minutes to a couple of hours. This rapid turnaround is unusual in psychiatry, where most treatments take days or weeks to show results.
That said, reaching the full therapeutic effect with scheduled dosing typically takes 3 to 7 days. The initial dramatic response confirms the diagnosis, but sustained improvement requires consistent dosing over that first week.
The Lorazepam Challenge Test
Because catatonia can look like other conditions and doesn’t always present the same way, clinicians often use something called a lorazepam challenge test to confirm the diagnosis. The idea is simple: give a dose of lorazepam and watch what happens. If catatonic signs like mutism, immobility, or rigid posturing improve noticeably within a short window, that response itself serves as strong evidence that catatonia is the correct diagnosis.
According to the American Psychiatric Association, this challenge test is the typical next step after catatonia is suspected on clinical examination. A positive response then guides the treatment plan going forward.
Typical Dosing and What Treatment Looks Like
Treatment usually starts at 1 to 2 mg given two to four times per day, depending on the clinical setting. Because lorazepam’s effects last roughly 10 to 19 hours, it needs to be given multiple times daily to maintain coverage. If the initial dose doesn’t produce an adequate response within 24 to 48 hours, the total daily dose is increased by about 2 mg per day.
This gradual increase continues until one of three things happens: the catatonia resolves, the patient becomes too sedated, or a ceiling of around 24 mg per day is reached. Most patients respond well below that ceiling. Older adults and people with certain medical conditions often need lower starting doses, sometimes just 1 mg twice daily. In rare, severe cases, doses as high as 48 mg per day have been documented, but this is exceptional.
Some patients with catatonia can’t swallow pills because their condition prevents them from cooperating with oral medication. In those cases, lorazepam can be given as an injection into muscle or through an IV line. After symptoms stabilize with IV treatment, guidelines recommend continuing IV dosing for at least 24 to 48 hours before switching to oral medication.
Response Rates by Underlying Cause
Catatonia isn’t a standalone illness. It occurs in the context of other conditions, including schizophrenia, mood disorders, autoimmune diseases, infections, and metabolic disturbances. Lorazepam’s effectiveness varies somewhat depending on the underlying cause, though it remains the go-to treatment across the board.
The strongest response rates show up in catatonia linked to schizophrenia, where studies report 60% to 85% of patients becoming catatonia-free within the first two hours and 85% to 100% within one day. Catatonia associated with mood disorders shows slightly lower initial response rates of 57% to 67% in the first two hours, but still reaches up to 100% within a day. When catatonia stems from a medical condition or substance use, about 86% of patients respond, though the timeline may be a bit longer.
One study from a developing country found a more conservative picture: complete resolution in about 32% of patients and meaningful improvement in roughly 69%, using doses of 3 to 6 mg per day for at least three days. The variation in reported success rates likely reflects differences in dosing, how quickly treatment started, and the severity of the underlying illness.
What Happens After Symptoms Resolve
Once catatonic symptoms clear, lorazepam isn’t stopped immediately. The effective dose is maintained while treatment for the underlying condition gets underway, whether that means antidepressants for a mood disorder, immunotherapy for an autoimmune condition, or another targeted treatment. Once the underlying cause is being addressed, the lorazepam dose is tapered gradually. Stopping abruptly risks a relapse of catatonic symptoms.
If lorazepam doesn’t produce a meaningful response within 7 days, or if dangerous features develop (high fever, extreme rigidity, autonomic instability), clinicians move to other interventions. Electroconvulsive therapy is the best-established second-line option and is particularly important when catatonia becomes life-threatening. For chronic catatonia that persists over weeks or months, lorazepam remains the first-line approach, sometimes at doses maintained over extended periods.
Why Lorazepam Over Other Benzodiazepines
Other benzodiazepines also enhance GABA activity, and some have been used for catatonia. But lorazepam has become the standard for practical reasons. It has a moderate half-life that allows flexible dosing throughout the day. It can be reliably absorbed through intramuscular injection, which matters when patients can’t take pills. And it has the deepest evidence base, with decades of clinical studies specifically documenting its use in catatonia. The American Psychiatric Association notes that lorazepam is the best-described benzodiazepine in the catatonia literature, which is why it remains the default choice.